Literature DB >> 3323396

Regulation of the synthesis of nerve growth factor.

R Heumann1.   

Abstract

Through nearly 40 years of research nerve growth factor (NGF) has become a paradigm for neurotrophic factors. NGF is synthesized and released from innervated target tissues in limiting amounts, thereby regulating the cell number and the differentiated properties of responsive neurones. Three distinct cell types are responsive to NGF: peripheral sensory and sympathetic neurones and certain types of central cholinergic ones. The effects of NGF are mediated through interaction with a specific receptor which activates a transmembrane second-messenger system. NGF synthesis is regulated during development and in the adult animal. In the developing whisker pad, NGF synthesis commences with its sensory innervation, but sensory neurones lack NGF receptors at the stage when their fibres are growing to their target. These findings indicate that NGF does not attract sensory nerve fibres chemotactically to their target fields during development, but is involved in target-controlled neuronal cell death and in regulation of the density of innervation of target tissues. In non-neuronal cells of the sciatic nerve, NGF synthesis is up-regulated during development and after nerve lesion. Thus the changes in NGF levels after lesion in the adult animal are consistent with the hypothesis that the non-neuronal cells relapse into an earlier developmental stage. Regenerating fibres penetrating into the distal nerve stump restore the low adult levels of NGF. Recent evidence indicates that macrophages invading the nerve after transection produce signals which increase NGF synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323396     DOI: 10.1242/jeb.132.1.133

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  9 in total

1.  Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor.

Authors:  Y O Taiwo; J D Levine; R M Burch; J E Woo; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 2.  Stress-induced remodeling of lymphoid innervation.

Authors:  Erica K Sloan; John P Capitanio; Steve W Cole
Journal:  Brain Behav Immun       Date:  2007-08-13       Impact factor: 7.217

3.  Stress and reactivation of latent herpes simplex virus: a fusion of behavioral medicine and molecular biology.

Authors:  F J Jenkins; A Baum
Journal:  Ann Behav Med       Date:  1995

Review 4.  Clinical strategies to enhance nerve regeneration in composite tissue allotransplantation.

Authors:  Simone W Glaus; Philip J Johnson; Susan E Mackinnon
Journal:  Hand Clin       Date:  2011-11       Impact factor: 1.907

5.  Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface.

Authors:  Gen Inoue; Alban Gaultier; Xiaoqing Li; Elisabetta Mantuano; George Richardson; Kazuhisa Takahashi; W Marie Campana
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

6.  Semiquantitative assessment of optic nerve injury using manganese-enhanced MRI.

Authors:  Jun Yang; Qinqing Li; Mary Wang; Xia Cao; Yingying Ding; Guanshun Wang; Chengde Liao
Journal:  Jpn J Radiol       Date:  2016-03-04       Impact factor: 2.374

7.  Bilateral phasic increases in dorsal root ganglia nerve growth factor synthesis after unilateral sciatic nerve crush.

Authors:  M R Wells; U Vaidya; J P Schwartz
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

8.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

9.  Can nerve regeneration on an artificial nerve conduit be enhanced by ethanol-induced cervical sympathetic ganglion block?

Authors:  Yoshiki Shionoya; Katsuhisa Sunada; Keiji Shigeno; Akira Nakada; Michitaka Honda; Tatsuo Nakamura
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.